Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q2 2026)
5,875
Value
$1.44M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AXSM by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,875$1.44M<0.1%−170−2.8%ReducedHolders
Q1 20266,045$1.02M<0.1%−135−2.2%ReducedHolders
Q4 20256,180$1.13M<0.1%00.0%UnchangedHolders
Q3 20256,180$750.6K<0.1%−475−7.1%ReducedHolders
Q2 20256,655$694.7K<0.1%−100−1.5%ReducedHolders
Q1 20256,755$787.8K<0.1%−1,475−17.9%ReducedHolders
Q4 20248,230$696.3K<0.1%+70+0.9%AddedHolders
Q3 20248,160$733.3K<0.1%−1,255−13.3%ReducedHolders
Q2 20249,415$757.9K<0.1%+375+4.1%AddedHolders
Q1 20249,040$721.4K<0.1%+1,800+24.9%AddedHolders
Q4 20237,240$576.2K<0.1%−190−2.6%ReducedHolders
Q3 20237,430$519.3K<0.1%−15−0.2%ReducedHolders
Q2 20237,445$535.0K<0.1%−75−1.0%ReducedHolders
Q1 20237,520$463.8K<0.1%−2,410−24.3%ReducedHolders
Q4 20229,930$765.9K<0.1%−850−7.9%ReducedHolders
Q3 202210,780$481.0K<0.1%−4,400−29.0%ReducedHolders
Q2 202215,180$581.0K<0.1%+170+1.1%AddedHolders
Q1 202215,010$621.0K<0.1%+675+4.7%AddedHolders
Q4 202114,335$542.0K<0.1%−1,990−12.2%ReducedHolders
Q3 202116,325$538.0K<0.1%+6,990+74.9%AddedHolders
Q2 20219,335$630.0K<0.1%+355+4.0%AddedHolders
Q1 20218,980$508.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.